Research shows that subjects with JAK2 mutations present an increased proportion of circulating MDSCs, which correlates with disease progression, substantial immunosuppressive mechanisms, and distinctive tumor-promoting and metastatic attributes [123]. The gene discussed is JAK2; the disease is neoplasm.